Igenica Biotherapeutics
Burlingame, US · Delaware corporation · 3 known investors
Founders & leadership
JC
John CelebiExecutive
MH
Mary Haak-FrendschoNamed on SEC filing
GA
Gwen A. FyfeNamed on SEC filing
Board
JD
CG
DG
David GoeddelBoard director
RS
Robert SchreiberBoard director
MG
Mark GoldsmithBoard director
GF
Gwen FyfeBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$15.6M disclosed across 4 rounds · 2014–2015
▶$2.3MraisedOct 2015 · 10 investors · PharmaceuticalsRule 506(b)
▶$2.3MraisedOct 2015 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mark GoldsmithDirector
- John CelebiExecutive Officer
- John DiekmanDirector
- Robert SchreiberDirector
- David GoeddelDirector
- Gwen FyfeDirector
- Offering amount
- $5M
- Amount sold
- $2.3M
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedJun 2015 · 8 investors · PharmaceuticalsRule 506(b)
▶$1.2MraisedJun 2015 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mark GoldsmithDirector
- David GoeddelDirector
- Gwen FyfeDirector
- Robert SchreiberDirector
- John CelebiExecutive Officer
- John DiekmanDirector
- Offering amount
- $4M
- Amount sold
- $1.2M
- First sale
- May 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.1MraisedJan 2015 · 10 investors · PharmaceuticalsRule 506(b)
▶$5.1MraisedJan 2015 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert SchreiberDirector
- John CelebiExecutive Officer
- John DiekmanDirector
- Mark GoldsmithDirector
- Carl GordonDirector
- David GoeddelDirector
- Gwen FyfeDirector
- Offering amount
- $6.3M
- Amount sold
- $5.1M
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedFeb 2014 · 7 investors · PharmaceuticalsRule 506(b)
▶$7MraisedFeb 2014 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert SchreiberDirector
- Carl GordonDirector
- John CelebiExecutive Officer
- David GoeddelDirector
- Mark GoldsmithDirector
- John DiekmanDirector
- Mary Haak-FrendschoExecutive Officer, Director
- Gwen A. FyfeDirector
- Offering amount
- $14.1M
- Amount sold
- $7M
- First sale
- Jan 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Igenica Biotherapeutics's investors?
- Igenica Biotherapeutics's investors include 5AM Ventures, OrbiMed, The Column Group.
- How much funding has Igenica Biotherapeutics raised?
- Igenica Biotherapeutics has disclosed $15.6M raised across 4 rounds.
- Where is Igenica Biotherapeutics headquartered?
- Igenica Biotherapeutics is headquartered in Burlingame, US.